NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 230 filers reported holding NEKTAR THERAPEUTICS in Q2 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,433,000 | -88.0% | 447,820 | -85.8% | 0.34% | -88.0% |
Q2 2022 | $11,970,000 | +2120.8% | 3,150,000 | +3050.0% | 2.87% | +2108.5% |
Q1 2022 | $539,000 | -80.4% | 100,000 | -51.0% | 0.13% | -78.8% |
Q4 2021 | $2,755,000 | -69.6% | 203,900 | -59.6% | 0.61% | -71.0% |
Q3 2021 | $9,064,000 | -76.6% | 504,691 | -76.2% | 2.11% | -40.7% |
Q3 2019 | $38,707,000 | – | 2,125,000 | – | 3.56% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 432,952 | $1,385,000 | 0.91% |
GREAT POINT PARTNERS LLC | 447,820 | $1,433,000 | 0.34% |
Birchview Capital, LP | 128,000 | $410,000 | 0.29% |
Edgestream Partners, L.P. | 1,047,636 | $3,352,000 | 0.26% |
Rhenman & Partners Asset Management AB | 550,000 | $2,068,000 | 0.22% |
CM Management, LLC | 50,000 | $160,000 | 0.18% |
TANG CAPITAL MANAGEMENT LLC | 430,037 | $1,376,000 | 0.17% |
PDT Partners, LLC | 307,953 | $985,000 | 0.15% |
Virtus ETF Advisers LLC | 72,018 | $230,000 | 0.09% |
ALGERT GLOBAL LLC | 476,412 | $1,525,000 | 0.09% |